Metacare Co., Ltd. (118000.KS) distributes pharmaceuticals and medical devices primarily in South Korea. The company wholesales and distributes orthopedic medical devices and consumables, including prodisc, hemostatic matrix, coolive tab, and artificial joints; provides pharmaceutical integration services and professional logistics; and engages in investment advisory and management consulting. It operates through four segments: pharmaceuticals distribution, medical devices and supplies, investment, and real estate services involving leasing and management of non-residential buildings.
Founded in 2009 and headquartered in Hwaseong-si, South Korea, Metacare serves the healthcare sector, targeting hospitals, clinics, and related institutions with medical equipment, appliances, health products, and pharmaceuticals.
In August 2024, the company changed its name from SMeDi Co., Ltd. to Metacare Co., Ltd., reflecting a strategic rebranding amid its focus on medical distribution and related services; it employs 22 to 32 staff and maintains operations centered in South Korea.